In the absence of GLI1 molecular testing, GLI1 immunohistochemistry can serve as a valuable diagnostic adjunct, aiding in the differentiation of GLI1-altered mesenchymal tumors. Here, GLI1 is linked to mesenchymal cell neoplasm.